Needlefree vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using nanopatch technology developed by. What we have been able to show for the first time is that the nanopatch is completely dissolvable, professor kendall said. Professor kendall said the nanopatch had been used to administer an inactivated type 2 poliovirus vaccine in a rat model. Nanopatch polio vaccine delivers uq news the university. Professor kendall said the nanopatch was much smaller than a postage stamp and comprised of several thousands of densely packed projections invisible to the human eye. Sep 23, 2014 professor mark kendall is working on the development of the needlefree nanopatch, to revolutionize delivery of vaccines in the developing world making them cheaper and potentially saving. Two exciting new alternatives to needle and syringe vaccines could have a considerable impact on global health. Nanopatch administers vaccines painlessly national. Nanopatchrevolutionising treatment of disease across the. The support specifically assists preclinical studies and good manufacturing practices.
He is an entrepreneurial professor of the australian national university. Mark kendall earned the young florey medal in 2016 for developing a breakthrough in vaccines. One thing is for certain, this is clearly just the start of an extensive and distinguished research programme with enormous potential for impact and public benefit. Its portability could help lower global mortality rates from tuberculosis. Dry, needlefree vaccines exist and are saving lives. Mark has published more than 200 papers and is an inventor on more than patents. Professor mark kendall is planning to dispatch the 160yearold needle and syringe to history. Arc future fellow pioneers needlefree immunisation for. Professor mark kendall, an inaugural arc future fellow at the. Needlefree nanopatch vaccines benefits and history. Arc future fellow pioneers needlefree immunisation for the. Christiana agyei, dr david muller, professor mark kendall, dr germain fernando and nick owens needlefree nanopatch technology developed at the university of queensland in australia has been used to deliver an inactivated poliovirus vaccine. Professor mark kendall was all set for a career in aerodynamics when he met a man with an unusual idea. After 160 years, its time to throw away the needle and syringe.
He is founder and ceo of wearoptimo pty ltd, and the vicechancellors entrepreneurial professor at the australian national university. Targeting the skin for needlefree, minimally invasive delivery and diagnostics for disease. Nov 26, 2012 millions of lives are likely to be saved thanks to the ingenuity and determination of mark kendall and his team. The study was published recently in scientific journal small.
Professor mark kendall has more than 18 years of experience researching the field of needlefree gene and drug delivery to skin and diagnostics devices with micronanostructures. Feb 25, 20 uq startup vaxxas is developing needlefree vaccination technology based on the research of professor mark kendall at the australian institute for bioengineering and nanotechnology. Looking a bit like a fuzzy computer chip, the nanopatch uses tiny powdercoated spikes to deliver a small dose of vaccine just under the skin, immunizing a person in about a minute. Kendall be phd frsa ftse born 1972 is an australian biomedical engineer, inventor, scientist and entrepreneur. Developed by university queensland bioengineer professor mark kendall, the nanopatch is a one centimetre square of silicone, studded with 20,000 vaccine coated micro projections that perforate the. After 160 years, its time to throw away the needle and.
Arc future fellow pioneers needlefree immunisation for the world. The university of queenslands main commercialisation arm, uniquest, led the initial commercialisation of the nanopatch technology prior to the creation of vaxxas in. Uq technology with the power to revolutionise global vaccine. Nov 05, 2015 view mark kendalls profile on linkedin, the worlds largest professional community. Nanopatch offering global impact about uq the university of. With the nanopatch seemingly poised to revolutionise vaccine delivery around the world, professor mark kendall has become a new torchbearer for australian research internationally.
Nanopatch creator mark kendall science meets business. Professor mark kendall, a university of queensland researcher who invented the nanopatch a needlefree vaccine delivery device has been awarded the 2016 csl young florey medal the award. He is founder and ceo of wearoptimo pty ltd, and the vicechancellors entrepreneurial professor at the australian national university kendall was formerly the professor of biomedical engineering and the university of queensland, where he led a team at the australian. Needlefree vaccines are pain free and cost effective ieee. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
Professor kendall heads a team responsible for the development of the nanopatch, a breakthrough technology that is a bit like a postage stamp that sticks on the skin. Mark kendall australian national university, canberra anu. One such method is the nanopatch, a fingertipsized patch covered in thousands of vaccinecoated microscopic spikes, developed by professor mark kendall and. Oct 05, 2017 a fresh study of the nanopatch a microscopic. Invented by professor mark kendall and his team, the nanopatch has received numerous awards including a eureka prize and a rolex laureate. Mark kendall wins csl young florey medal with nanopatch. Nov 14, 2016 biomedical engineer mark kendall s needlefree nanopatch is tinier than a postage stamp but huge on potential impact. Intrigued, kendall accepted the mans offer to work at oxford university, where together with others. Professor mark kendall from university of queenslands institute for biotechnology and nanotechnology and his team have only tested this type of immunization on mice using various inoculations. In animals treated with influenza vaccines, nanopatch induced immune response with a tiny dose which was ten times better than any other way of application. One such method is the nanopatch, a fingertipsized patch covered in thousands of vaccinecoated microscopic spikes, developed by professor mark kendall and his research team at the university of queenslands institute for biotechnology and nanotechnology. The technology reduces the dose required to achieve immunity by targeting the skins immune system, rather than requiring injection into a muscle, and removes the need. So, what did the professor at the university of queensland invent. Apr 22, 2010 new research, led by professor mark kendall, from uqs australian institute for bioengineering and nanotechnology, demonstrates that a vaccine delivered by a nanopatch induces a.
Now the professor is working with vaxxas and the schools institute for bio. Nanopatch polio vaccine success uq news the university of. Project leader professor mark kendall said the finding confirmed that the nanopatch was a potential safer, cheaper alternative to needle vaccines. The money will enable university of queenslands professor.
Needlefree vaccines are pain free and cost effective. Hes invented a new vaccine technology thats painless, uses a fraction of the dose, puts the vaccine just under the skin, and doesnt require a fridge. At the university of oxford 19982006, i was a university research lecturer and college lecturer. The nanopatch is just as effective as needlebased mechanisms, said. He is founder and ceo of wearoptimo pty ltd, and the vicechancellors entrepreneurial professor at the australian. Professor mark kendall, an inaugural arc future fellow who has also received support from the arc discovery projects scheme, developed nanopatch. Mark kendall aims to shake up how vaccines are delivered with the nanopatch. Mark kendall talks about nanopatch the partnership has the potential to be a gamechanger for polio vaccines, said professor mark kendall, vaxxas founder and chief technology. Nanopatch professor mark kendall is a worldleading innovator in producing technology solutions to global health problems. See the complete profile on linkedin and discover marks connections and jobs at similar companies.
Oct 05, 2017 the support specifically assists preclinical studies and good manufacturing practices. Oct, 2014 but while professor mark kendall of the australian institute for bioengineering and nanotechnology is the public face of the revolutionary nanopatch, it has taken a vast team of researchers from a. Kendalls work drew the attention of the cdc and the world health organization. Nanopatch polio vaccine success uq news the university. Nanopatch may represent the future of vaccine delivery. Professor mark kendall is the 2016 winner of the csl young florey medal, in recognition of his worldleading work on the nanopatch. I want to make a difference and to be remembered as. Australian researchers use nanopatch to deliver polio vaccine. Mark kendall founder and chief executive officer wearoptimo.
Jun 14, 20 medical xpress professor mark kendall of the university of queensland, australia, has announced at this years tedglobal conference that a skin patch he and colleagues have developed will soon. Nanopatch technology developed by professor mark kendall could have a global impact by improving vaccines so they no longer have to be. Nanopatch polio vaccine delivers uq news the university of. Nanopatch is a small square of silicon that sticks on the skin like a postage stamp and delivers vaccine directly to the bodys immune system. Rocket scientistturnedimmunology expert mark kendall talks about. We compared the nanopatch to the traditional needle and syringe, and found that there is about a 40fold improvement in delivered dosesparing, professor kendall said. University of queensland professor mark kendall wins csl. At the univeristy of queensland 20062018 kendall invented the nanopatch. Uq technology with the power to revolutionise global. Professor mark kendall, an inaugural arc future fellow at the university of queensland, is a pioneer in needlefree immunisation technology that promises to eliminate the need for needles and syringes for vaccine delivery. Nanopatch a needlefree vaccine device wins florey medal.
Delivery of a polio vaccine with the nanopatch was demonstrated by uqs professor mark kendall and his research team at uqs australian institute for bioengineering and nanotechnology, in. The nanopatch technology has been licensed to us based pharmaceutical company merck and co. It targets the abundant immune cell populations in the skins outer layers, rather than muscle, resulting in a more efficient vaccine delivery system, professor kendall said. A stereo microscope pictured allows professor mark kendall to study a nanopatch with the high degree of detail necessary to produce this microtechnology. Uq researchers develop a dissolvable needlefree nanopatch. Nanopatch polio vaccine delivers, research indicates. I am a vicechancellors entrepreneurial professor at anu. Patch inventor professor mark kendall said the study exhibited a key advantage of the nanopatch. The nanopatch technology originated from professor mark kendall s research group at the australian institute of bioengineering and nanotechnology at the university of queensland.
389 1056 1027 1168 304 161 595 198 969 1423 703 462 64 211 218 1462 1343 1217 1055 290 150 66 856 1344 458 900 613 826 258 614 298 372 1324 1151 1452 248 800 1379 530 499 375 695